Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challengeDaphne A. Stanley, Nancy J. Sullivan, Kathryn E. Foulds et al.|Nature Medicine|2014Cited by 352
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primatesNancy J. Sullivan, Gary J. Nabel, Lisa E. Hensley et al.|Nature Medicine|2011Cited by 227
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus ChallengeThomas W. Geisbert, Nancy J. Sullivan, Michael Bailey et al.|Journal of Virology|2011Cited by 225
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus SpeciesLisa E. Hensley, Nancy J. Sullivan, Sabue Mulangu et al.|PLoS Pathogens|2010Cited by 145
Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman PrimatesThomas W. Geisbert, Nancy J. Sullivan, Michael Bailey et al.|Journal of Virology|2010Cited by 82